The Hematology Research Symposium on June 8-9, 2018 will feature a host of internal and external experts promoting the many strengths of hematologic research including lymphoid and myeloid malignancies, immunotherapy...
Michael Deininger, MD, PhD (Division of Hematology) weighs in on the announcement that the Huntsman Cancer Institute has been certified to offer both chimeric antigen receptor (CAR) T cell therapies...
Congratulations to Mike Deininger, MD, PhD, for his appointment as Director of the Huntsman Center of Excellence in Hematological Malignancies and Hematology.
